69 related articles for article (PubMed ID: 3387315)
1. [Results of treatment by the PUVA method in patients with atopic dermatitis].
Cisło M; Maj J
Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):103-6. PubMed ID: 3387315
[No Abstract] [Full Text] [Related]
2. [Photochemotherapy via oral route and atopic dermatitis].
Binet O; Aron-Brunetiére R; Cunéo M; Césaro MJ
Ann Dermatol Venereol; 1982; 109(6-7):589-90. PubMed ID: 7187186
[No Abstract] [Full Text] [Related]
3. [Treatment of atopic dermatitis and seborrheic dermatitis with selective UV-phototherapy and PUVA. A comparative study].
Salo O; Lassus A; Juvakoski T; Kanerva L; Lauharanta J
Dermatol Monatsschr; 1983 Jun; 169(6):371-5. PubMed ID: 6224707
[No Abstract] [Full Text] [Related]
4. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro.
Yoshimura M; Namura S; Akamatsu H; Horio T
Br J Dermatol; 1996 Oct; 135(4):528-32. PubMed ID: 8915140
[TBL] [Abstract][Full Text] [Related]
6. [Bullous pemphigoid precipitated by PUVA therapy].
Bastian P; Drobacheff C; Laurent R
Ann Dermatol Venereol; 1990; 117(10):734. PubMed ID: 2073069
[No Abstract] [Full Text] [Related]
7. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice.
Miyauchi-Hashimoto H; Okamoto H; Sugihara A; Horio T
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):125-30. PubMed ID: 15888128
[TBL] [Abstract][Full Text] [Related]
8. [Advantan for therapy of atopic dermatitis].
Beridze LR; Zosidze NR
Georgian Med News; 2009 Jun; (171):31-3. PubMed ID: 19578209
[TBL] [Abstract][Full Text] [Related]
9. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anti-IgE therapy in patients with atopic dermatitis.
Vigo PG; Girgis KR; Pfuetze BL; Critchlow ME; Fisher J; Hussain I
J Am Acad Dermatol; 2006 Jul; 55(1):168-70. PubMed ID: 16781320
[No Abstract] [Full Text] [Related]
11. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Yanase DJ; David-Bajar K
J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
[TBL] [Abstract][Full Text] [Related]
12. [Chloroquine--therapy of atopic dermatitis].
Döring HF; Müllejans-Kreppel U
Z Hautkr; 1987 Aug; 62(16):1205-13. PubMed ID: 3673157
[TBL] [Abstract][Full Text] [Related]
13. Ketotifen in the treatment of atopic dermatitis. Results of a double blind study.
Falk ES
Riv Eur Sci Med Farmacol; 1993; 15(2):63-6. PubMed ID: 8171216
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
15. Failure of omalizumab for treatment of severe adult atopic dermatitis.
Krathen RA; Hsu S
J Am Acad Dermatol; 2005 Aug; 53(2):338-40. PubMed ID: 16021135
[TBL] [Abstract][Full Text] [Related]
16. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
17. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Blum G; Kröpfli P; Küng D; Suter H
Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
[No Abstract] [Full Text] [Related]
18. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
Capella GL; Grigerio E; Altomare G
Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
[TBL] [Abstract][Full Text] [Related]
20. Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses.
Williams HC
Arch Dermatol; 2004 Sep; 140(9):1151-2. PubMed ID: 15381558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
